Related Experiment Videos
[Recurrent peptic ulcer after gastric surgery].
1Dept. of Critical Care and Emergency Medicine, Yokohama.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 1, 1992
Summary
Proton pump inhibitors like omeprazole effectively heal recurrent peptic ulcers after gastric surgery. This treatment offers rapid symptom relief and complete healing within eight weeks, outperforming H2-blockers.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Pharmacology
Background:
- Recurrent peptic ulcers post-gastric surgery present unique challenges due to typically low acid output.
- Proton pump inhibitors (PPIs) offer potent, long-acting acid suppression, suggesting potential efficacy over H2-blockers for these ulcers.
Purpose of the Study:
- To evaluate the efficacy of omeprazole (OPZ), a PPI, in treating recurrent peptic ulcers following gastric surgery.
- To compare the healing rates and symptom relief provided by omeprazole versus H2-blockers.
Main Methods:
- A study involving 12 patients who underwent gastrectomy or vagotomy and developed recurrent ulcers.
- Treatment with omeprazole (OPZ) for a duration of 8 weeks.
- Assessment of ulcer healing rates and symptom relief.
Main Results:
- Omeprazole achieved a 58% healing rate after 4 weeks of treatment.
- The healing rate increased to 100% after 8 weeks of omeprazole treatment.
- Patients reported significant and rapid symptom relief, supporting omeprazole's efficacy.
Conclusions:
- Omeprazole demonstrates high efficacy in healing recurrent peptic ulcers after gastric surgery, with rapid symptom relief.
- The 8-week omeprazole treatment achieved complete healing in all evaluated patients.
- Further research is needed to determine long-term relapse rates after PPI discontinuation and the role of maintenance PPI therapy.